D-cycloserine zwitterion is a zwitterion resulting from the transfer of a proton from the ring nitrogen to the primary amino group of D-cycloserine. The major species at pH 7.3. It is a tautomer of a D-cycloserine.
-20 °C · Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Safety data
F
10-23
PPE
Eyeshields, Gloves, type N95 (US)
wgk
2
rtecs
NY2975000
hs_code
29419090
risk_code
5-20
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
38-36/37-24/25
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319-H335
Precautionary statements
P271-P261-P280
Hazardous Substances Data
68-41-7(Hazardous Substances Data)
Chemistry & industry
Pharmacology
Pharmacodynamics · 1 item
Cycloserine, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. Cycloserine works by blocking the formation of these peptidoglycans. By doing this the walls of the bacteria become weak and it results in the death of the bacteria
Mechanism of Action · 1 item
Cycloserine is an analog of the amino acid D-alanine. It interferes with an early step in bacterial cell wall synthesis in the cytoplasm by competitive inhibition of two enzymes, L-alanine racemase, which forms D-alanine from L-alanine, and D-alanylalanine synthetase, which incorporates D-alanine into the pentapeptide necessary for peptidoglycan formation and bacterial cell wall synthesis.
Biological Half-LifeHalf-life in patients with normal renal function is 10 hours, and is prolonged in patients with impaired renal function.
Absorption, Distribution and ExcretionRapidly and almost completely absorbed (70 to 90%) from the gastrointestinal tract following oral administration.
Cellular LocationsCytoplasm
Applications · 6 items
UsesUsed as an antibiotic medicine in the treatment of drug-resistant Mycobacterium tuberculosis infection. Biochemical research
DescriptionD-Cycloserine (68-41-7) is a partial agonist at the glycine modulatory site of NMDA glutamatergic receptors.1Blocks kainate-induced seizures2and displays anticonvulsant effects3in rat models. D-Cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices.4Second-line drug for the treatment of tuberculosis. Enhances activity-dependent plasticity in human adults.5
UsesD-cycloserine has been used to inhibit serine hydroxymethyltransferase.
UsesD-Cycloserine inhibits cell wall biosynthesis (D-Ala peptide bond formation). D-Cycloserine also prevents conversion of D-Ala to L-Ala. D-Cycloserine is an bacteriostatic. D-Cycloserine is an antibiot ic against Gram-negative bacteria.
General DescriptionChemical structure: amino acid derivatives
DefinitionChEBI: D-cycloserine is a 4-amino-1,2-oxazolidin-3-one that has R configuration. It is an antibiotic produced by Streptomyces garyphalus or S. orchidaceus and is used as part of a multi-drug regimen for the treatment of tuberculosis when resistance to, or toxicity from, primary drugs has developed. An analogue of D-alanine, it interferes with bacterial cell wall synthesis in the cytoplasm by competitive inhibition of L-alanine racemase (which forms D-alanine from L-alanine) and D-alanine--D-alanine ligase (which incorporates D-alanine into the pentapeptide required for peptidoglycan formation and bacterial cell wall synthesis). It has a role as an antitubercular agent, an antiinfective agent, an antimetabolite, a metabolite and a NMDA receptor agonist. It is an organooxygen heterocyclic antibiotic, an organonitrogen heterocyclic antibiotic and a 4-amino-1,2-oxazolidin-3-one. It is a conjugate base of a D-cycloserine(1+). It is an enantiomer of a L-cycloserine. It is a tautomer of a D-cycloserine zwitterion.